Payers

Myasthenia Care Cannot Wait for Crisis

Do patients need maximum-dose tirzepatide forever? New data suggest a middle ground

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era

Duchenne’s Cell Therapy Gets More Time, Not Certainty

Radiopharmaceuticals Just Got a Necessary No

Alzheimer’s Blood Tests Are Becoming the Gate

Tourette Care Has Waited Too Long

Medical Debt Is Becoming a Cancer Stage

Narcolepsy Gets Treated at the Cause
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
